$0.0112
-0.00940-45.63%
At close: -
$0.0195
0.0083074.11%
After Hours: Oct 30, 8:16 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Tryptamine Therapeutics in recent months.
Browse guidance and forecast on all stocks.